Popular weight-loss drugs linked to rare ‘pirate disease,’researchers warn

[aggregator] downloaded image for imported item #37890

This post was originally published on this site.

Researchers in Australia are raising flags about GLP-1 weight-loss medications potentially raising the risk of a rare disease.

Scurvy — historically called a “pirate disease” due to long voyages at sea withoutnutritious food— is caused by a lack of vitamin C.If left untreated, scurvy can cause severe symptoms, according to Cleveland Clinic.

Those symptoms include anemia,loosened teeththat may fall out, bleeding under the skin, bruising, swollen legs, rough and scaly skin, dry and brittle hair that coils, and the re-opening of wounds that do not heal.Swollen, bleeding gums are another common result.

NEW WEIGHT-LOSS SHOT SHOWS MAJOR FAT REDUCTION, BUT EXPERTS URGE CAUTION

The disease could surface as the result of not properly providing the body withnutrient-rich foods,leading to malnourishment.New research suggests that GLP-1 drug users may be at greater risk.

A systematic review by the Hunter Medical Research Institute in Australia found that although diabetes andobesity medicationssupport significant improvements in weight loss, clinical trials have “failed to report what people are actually eating while taking them.”

split image of a pirates flag and weight loss injections

Weight-loss medications could lead to diseases caused by vitamin deficiencies, such as scurvy.(iStock)

“A reduction in body weight does not automatically mean the person iswell-nourished or healthy,” Clare Collins, laureate professor of nutrition and dietetics at The University of Newcastle, Australia, wrote in a press release statement.“Nutrition plays a critical role in health, and right now it’s largely missing from the evidence.”

These findings raise “major concerns about the risk of malnutrition, including macro and micro-nutrient deficiencies, with adverse metabolic and nutritional effects being reported,�

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

Certain GLP-1 and GIP medications have a “major impact” on appetite and satiety, which leads to overall reduced food intake, according to the researcher.

The signs can be missed because they overlap initially with side effects of the medications.

“While this mechanism drivesweight loss, it also increases the risk of inadequate protein, fiber, vitamin and mineral intakes if diet quality and nutritional adequacy are not carefully monitored,” she cautioned.

British pop singer Robbie Williams was diagnosed with scurvy in 2025, previously sharing withThe Mirrorthat he experienced symptoms of the “17th-century pirate disease” after he’d been taking “something like Ozempic.”

Robbie Williams at the 2026 FIFA World Cup draw

British pop singer Robbie Williams was diagnosed with scurvy in 2025, previously sharing with The Mirror that he experienced symptoms of the “17th-century pirate disease” after he’d been taking “something like Ozempic.”(Sam Corum/PA Images via Getty Images)

Collins noted that nutrient deficiencies are “not specific” to scurvy.

“There are other nutrients that, if not consumed in adequate amounts, can lead to deficiencies,” she said.

person stands on scale holding GLP1 injection

“A reduction in body weight does not automatically mean the person is well-nourished or healthy,” one expert said.(iStock)

Nutrition in focus

For GLP-1 users who are losing weight quickly, Collins emphasized the importance of an adequate intake of nutrients, vitamins and minerals.

proper nutrition, Collins recommends seeking professional help from an accredited dietitian.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top